mouse anti-human braf v600e monoclonal antibody (clone ve1) (Spring Bioscience)
Structured Review

Mouse Anti Human Braf V600e Monoclonal Antibody (Clone Ve1), supplied by Spring Bioscience, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti-human+braf+v600e+(clone+ve1)+monoclonal+antibody/braf+v600e+antibody/pmc07801318-75-1-6
Average 90 stars, based on 1 article reviews
Images
1) Product Images from "Quantitative and Spatial Analysis of CD8+/PD-1 Tumor-Infiltrating Lymphocytes as a Predictive Biomarker for Clinical Response of Melanoma In-Transit Metastases to Topical Immunotherapy"
Article Title: Quantitative and Spatial Analysis of CD8+/PD-1 Tumor-Infiltrating Lymphocytes as a Predictive Biomarker for Clinical Response of Melanoma In-Transit Metastases to Topical Immunotherapy
Journal: Annals of Surgical Oncology
doi: 10.1245/s10434-020-08713-1
Figure Legend Snippet: Lymphocyte biomarkers and distribution by BRAF mutation status
Techniques Used: Mutagenesis
Figure Legend Snippet: Clinical response to DPCP correlated with OS by biomarker status
Techniques Used: Biomarker Discovery
Related Articles
Mutagenesis:Article Title: BRAF V600E Mutations Occur in a Subset of Glomus Tumors, and Are Associated With Malignant Histologic Characteristics Article Snippet: Glomus tumors are rare mesenchymal neoplasms with a phenotype akin to the modified smooth muscle cells of the glomus body.. Most are benign, but rare examples show malignant histologic characteristics and aggressive behavior.. We recently encountered a malignant glomus tumor with BRAF V600E mutation. Expressing:Article Title: BRAF V600E Mutations Occur in a Subset of Glomus Tumors, and Are Associated With Malignant Histologic Characteristics Article Snippet: Glomus tumors are rare mesenchymal neoplasms with a phenotype akin to the modified smooth muscle cells of the glomus body.. Most are benign, but rare examples show malignant histologic characteristics and aggressive behavior.. We recently encountered a malignant glomus tumor with BRAF V600E mutation. Immunohistochemistry:Article Title: BRAF V600E Mutations Occur in a Subset of Glomus Tumors, and Are Associated With Malignant Histologic Characteristics Article Snippet: Glomus tumors are rare mesenchymal neoplasms with a phenotype akin to the modified smooth muscle cells of the glomus body.. Most are benign, but rare examples show malignant histologic characteristics and aggressive behavior.. We recently encountered a malignant glomus tumor with BRAF V600E mutation. other:Article Title: Comparison of Molecular Methods and BRAF Immunohistochemistry (VE1 Clone) for the Detection of BRAF V600E Mutation in Papillary Thyroid Carcinoma: A Meta-Analysis Article Snippet: The majority of the studies used the Article Title: Quantitative analysis of wild-type and V600E mutant BRAF proteins in colorectal carcinoma using immunoenrichment and targeted mass spectrometry. Article Snippet: Immunoenrichment coupled with MRM or SIM-AIMS assay was evaluated for quantifying WT and V600E mutant BRAF proteins in CRC.. Both assays could successfully detect/ quantify both targets in a CRC cell line and CRC tissue samples.. Both targets could be quantified at the level of sub ng/mg protein Article Title: Long-Term Extracorporeal Membrane Oxygenation as Bridging Strategies to Lung Transplantation in Rapidly Devastating Isolated Langerhans Cell Histiocytosis. Article Snippet: Isolated pulmonary involvement in pediatric Langerhans cell histiocytosis (LCH) is extremely rare.. While the multisystem-LCH course varies from spontaneous remission to rapid deterioration with lethal outcome, single system involvement is generally associated with favorable prognosis.. A child with isolated pulmonary LCH had an extremely rapid progression leading to respiratory failure, despite treatment with prednisone and vinblastine. Article Title: BRAF and KRAS mutations in tubular apocrine adenoma and papillary eccrine adenoma of the skin. Article Snippet: BRAF and KRAS mutations in tubular apocrine adenoma and papillary eccrine adenoma of the skin Jau-Yu Liau MD, Jia-Huei Tsai MD, Wen-Chang Huang MD, Jui Lan MD, Jin-Bon Hong MD, Chang-Tsu Yuan MD PII: S0046-8177(17)30467-7 DOI: doi: 10.1016/j.humpath.2017.12.002 Reference: YHUPA 4419 To appear in: Human Pathology Received date: 26 September 2017 Revised date: 17 November 2017 Accepted date: 1 December 2017 Please cite this article as: Liau Jau-Yu, Tsai Jia-Huei, Huang Wen-Chang, Lan Jui, Hong Jin-Bon, Yuan Chang-Tsu, BRAF and KRAS mutations in tubular apocrine adenoma and papillary eccrine adenoma of the skin, Human Pathology (2017), doi: 10.1016/j.humpath.2017.12.002 This is a PDF file of an unedited manuscript that has been accepted for publication.. As a service to our customers we are providing this early version of the manuscript.. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Article Title: BRAF V600E Inhibitor (Vemurafenib) for BRAF V600E Mutated Low Grade Gliomas Article Snippet: As for immunohistochemistry, 3-micron paraffin embedded sections were dehydrated, pretreated with avidin block for 15' and biotin block for 15', then incubated with BSA for 30' and incubated with mouse anti-human BRAF V600E monoclonal antibody (clone VE1, Article Title: The clinicopathological features of ganglioglioma with CD34 expression and BRAF mutation in patients with epilepsy Article Snippet: Immunohistochemical staining was performed with the following primary antibodies: Article Title: Quantitative and Spatial Analysis of CD8+/PD-1 Tumor-Infiltrating Lymphocytes as a Predictive Biomarker for Clinical Response of Melanoma In-Transit Metastases to Topical Immunotherapy Article Snippet: For BRAF V600E IHC, Pleasanton, |

